We are live on ! Find out more
LFMD icon

LifeMD

114 hedge funds and large institutions have $139M invested in LifeMD in 2025 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 33 increasing their positions, 41 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more call options, than puts

Call options by funds: $5.22M | Put options by funds: $3.79M

9.52% less ownership

Funds ownership: 52.69%43.17% (-9.5%)

11% less funds holding

Funds holding: 128114 (-14)

20% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 41

36% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 39

57% less capital invested

Capital invested by funds: $326M → $139M (-$187M)

Holders
114
Holders Change
-14
Holders Change %
-10.94%
% of All Funds
1.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
25
Increased
33
Reduced
41
Closed
39
Calls
$5.22M
Puts
$3.79M
Net Calls
+$1.43M
Net Calls Change
-$6.42M
Name Holding Trade Value Shares
Change
Change in
Stake
S
151
SignatureFD
Georgia
-$163 -12 Closed
National Bank of Canada
152
National Bank of Canada
Quebec, Canada
-$54 -4 Closed
AF
153
Allworth Financial
California
-$28 -2 Closed

LFMD Hedge Fund Activity: Q3 2025 in Review

114 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in LifeMD (LFMD) for Q3 2025, worth a combined $139M — down 57% from $326M a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of LFMD and 25 opened new positions — a net loss of 14 holders — while 41 trimmed existing stakes and 33 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $5.43M. The largest seller was Connor, Clark & Lunn Investment Management (CC&L), exiting entirely with an estimated $12.6M sold.

  • 114 institutional investors held LifeMD (LFMD) as of Q3 2025, down from 128 in Q2 2025.
  • Funds reported $139M of LifeMD stock for Q3 2025, down 57% quarter-over-quarter.
  • 25 funds opened new LifeMD positions in Q3 2025 and 39 closed out, a net change of -14 holders.
  • The largest LifeMD buyer in Q3 2025 was Citadel Advisors, an estimated $5.43M added.
  • The largest LifeMD seller in Q3 2025 was Connor, Clark & Lunn Investment Management (CC&L), an estimated $12.6M sold.

Based on aggregated 13F filings for Q3 2025.